Notably, this TNFα- and IL-2-armed OV demonstrated synergy with mesothelin specific CAR T cells in a preclinical mouse model of pancreatic cancer [109], supported CAR T cell activity, with enhanced tumour regression and survival and prevention of metastases. Here, TNF is linked to neoplasm.